Clinical Trials Directory

Trials / Completed

CompletedNCT01878916

Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs

Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Hyperhomocysteinemia is a risk for thrombosis. Thrombosis is more frequent in myeloproliferative neoplasms (MPNs) than the normal population. In this study, we investigated the thrombosis incidence, the effects of plasma homocysteine levels on thrombosis, and the correlations between folate, cobalamin, pyridoxine and homocysteine levels in MPNs, and to compare these results with the healthy controls.

Detailed description

Thirty-one new or formerly diagnosed MPN patients who consecutively visitted our outpatient clinic, as well as 40 age and sex matched healthy controls were enrolled in this study.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2004-06-01
Completion
2004-06-01
First posted
2013-06-17
Last updated
2013-06-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01878916. Inclusion in this directory is not an endorsement.